Basel Medical (BMGL) received notification from Nasdaq that based on the company’s amended annual report on Form 20-F for FY25, filed with the SEC on March 13, Nasdaq has now determined that the company has complied with the periodic filing requirement for Nasdaq. Accordingly, the prior deficiency relating to the Periodic Filing Rule has now been resolved.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks